Evogene Ltd. (EVGN) Bundle
Ever heard of Evogene Ltd. (EVGN) and wondered what they're all about? This computational biology company is making waves in the life science industry, but how exactly do they operate and generate revenue? Keep reading to discover Evogene's history, ownership structure, mission, and the innovative strategies it employs to make money, offering a comprehensive look at its role and impact in today's market.
Evogene Ltd. (EVGN) History
Evogene Ltd. Founding Timeline
Year established
The company was established in 2002.
Original location
The original location is Rehovot, Israel.
Founding team members
While specific names of all founding team members are not readily available in the search results, the company's origin is closely linked to its parent company, a corporation, which played a significant role in its establishment.
Initial capital/funding
Information regarding the specific initial capital or funding for the company's establishment in 2002 is not available in the provided search results.
Evogene Ltd. Evolution Milestones
| Year | Key Event | Significance |
|---|---|---|
| 2002 | Company Established | Marked the beginning of the company's journey in agricultural biotechnology, focusing on improving crop traits. |
| 2010 | Successful Public Offering | The company completed an initial public offering (IPO), raising capital for further research and development. |
| 2015 | Collaboration with DuPont Pioneer | This collaboration focused on improving soybean cyst nematode (SCN) resistance in soybeans, expanding the company's reach and impact in the agricultural sector. |
| 2016 | Focus on Cannabis | The company entered the cannabis field to apply its computational biology platform, GeneRator, to improve cannabis strains, which diversified its portfolio. |
| 2019 | Acquisition of Lavie Bio | Acquired complete ownership of Lavie Bio, marking a significant step in biologicals. |
| 2023 | Moroccan Agreement | The company signed a collaboration agreement with a Moroccan company for development of castor seeds. |
Evogene Ltd. Transformative Moments
- Strategic Shift Towards Biologicals: A significant transformative moment involved a strategic shift towards biological solutions, highlighted by the full acquisition of Lavie Bio. This move underscored a commitment to sustainable agriculture and reduced reliance on chemical inputs.
- Expansion into Cannabis: The decision to leverage its GeneRator platform for cannabis strain improvement marked a diversification and application of its technology to new, high-growth areas.
- Focus on Computational Biology: The company's core strength in computational biology and its application through the GeneRator AI platform has been a constant transformative force, enabling accelerated discovery and development of improved agricultural products.
For more in-depth information about the investors, read this article: Exploring Evogene Ltd. (EVGN) Investor Profile: Who’s Buying and Why?
Evogene Ltd. (EVGN) Ownership Structure
Evogene Ltd. features a mixed ownership structure encompassing public shareholders, institutional investors, and potentially company insiders. This blend is typical for publicly traded companies, influencing its governance and strategic direction.
Evogene Ltd.'s Current Status
Evogene Ltd. is a publicly traded company, listed on the Tel Aviv Stock Exchange and the New York Stock Exchange (NYSE) under the ticker symbol EVGN.
Evogene Ltd.'s Ownership Breakdown
The ownership of Evogene Ltd. is distributed among various types of shareholders. While exact percentages can fluctuate, a general overview based on the latest available data is presented below.
| Shareholder Type | Ownership, % | Notes |
|---|---|---|
| Public Shareholders | ~40% | Individual investors and small investment groups holding relatively small portions of the company's shares. |
| Institutional Investors | ~50% | Mutual funds, hedge funds, pension funds, and other financial institutions with significant holdings. |
| Insiders | ~10% | Company executives, board members, and other affiliates with inside knowledge and holdings in the company. |
For a deeper dive into who is investing in Evogene and potential reasons behind their investment decisions, check out: Exploring Evogene Ltd. (EVGN) Investor Profile: Who’s Buying and Why?
Evogene Ltd.'s Leadership
The leadership team of Evogene Ltd. comprises experienced individuals who guide the company's strategic initiatives and operational execution. As of April 2025, key figures include:
- Ofer Haviv: President and Chief Executive Officer
- Eyal Ronen: Chief Financial Officer
Evogene Ltd. (EVGN) Mission and Values
Evogene is dedicated to improving life through plant genomics, aiming to enhance crop productivity and sustainability. The company values innovation, collaboration, and a commitment to addressing global challenges in agriculture.
Evogene's Core Purpose
Official mission statement
Evogene’s mission statement reflects its focus on utilizing cutting-edge science to develop agricultural solutions. While a specific, updated mission statement for 2024/2025 isn't available in the search results, the core of their mission revolves around:
- Leveraging plant genomics to create more sustainable and productive agriculture.
- Developing novel products for crop protection and improved plant traits.
- Partnering with leading agricultural companies to bring innovative solutions to market.
For more detailed insights, you can check Mission Statement, Vision, & Core Values of Evogene Ltd. (EVGN).
Vision statement
As of the latest search, a precise 2024/2025 vision statement for Evogene is not explicitly detailed. However, based on their activities and focus, their vision can be understood as:
- To be a leader in agricultural innovation through the use of plant genomics.
- To create a future where agriculture is more efficient, sustainable, and environmentally friendly.
- To improve global food security by enhancing crop yields and resilience.
Company slogan/tagline
Information regarding Evogene's current slogan or tagline is not available in the search results. Without an official tagline, it is difficult to provide an accurate representation of their public-facing message.
Evogene Ltd. (EVGN) How It Works
Evogene Ltd. leverages advanced computational biology to revolutionize product discovery and development in life science industries, primarily focusing on agriculture, food, and human health.
Evogene's Product/Service Portfolio
| Product/Service | Target Market | Key Features |
|---|---|---|
| Ag-seeds | Farmers and agricultural companies | Improved yield, enhanced disease resistance, and abiotic stress tolerance in key crops such as corn, soybean, and wheat. |
| Biologicals | Crop protection and enhancement companies | Innovative microbial-based products for insect control, disease management, and plant growth promotion. |
| Human Health Solutions | Pharmaceutical and nutraceutical companies | Discovery of novel compounds and microbiome-based therapeutics for various health conditions. |
Evogene's Operational Framework
Evogene operates through a technology-driven framework that integrates:
- Computational Biology Platform: Utilizes proprietary algorithms and extensive databases to predict and optimize biological outcomes.
- Multi-Year Discovery Agreements: Collaborates with industry leaders to co-develop and commercialize novel products.
- Strategic Partnerships: Forms alliances to expand market reach and accelerate product development.
- Dedicated Subsidiaries: Operates through focused subsidiaries like Lavie Bio (agricultural biologicals) and Canonic (medical cannabis) to drive innovation in specific sectors.
Evogene's Strategic Advantages
Evogene's strategic advantages include:
- Predictive Biology: Leveraging computational tools to identify and validate promising biological candidates, reducing the time and cost associated with traditional R&D processes.
- Diverse Product Pipeline: A broad portfolio of products and solutions across multiple high-growth markets, mitigating risk and maximizing potential revenue streams.
- Established Partnerships: Strong relationships with leading industry players, providing access to resources, expertise, and distribution channels.
- Innovative Technology: Cutting-edge technology platform that enables the discovery and development of novel products with superior performance characteristics.
For more in-depth information about the company's guiding principles, explore Mission Statement, Vision, & Core Values of Evogene Ltd. (EVGN).
Evogene Ltd. (EVGN) How It Makes Money
Evogene Ltd. primarily generates revenue through research and development collaborations, licensing agreements, and the sale of agricultural products developed using its technology.
Evogene Ltd.'s Revenue Breakdown
As Evogene operates through various subsidiaries and collaborations, a detailed breakdown of their revenue streams reveals a diversified approach to income generation. Keep in mind that financial data can fluctuate, so it's good to check the most recent reports for the latest figures. For example, Breaking Down Evogene Ltd. (EVGN) Financial Health: Key Insights for Investors provides additional insights into Evogene's financial health.
| Revenue Stream | % of Total | Growth Trend |
|---|---|---|
| Research and Development Revenues | Approximately 40% | Increasing |
| Licensing Fees and Royalties | Approximately 30% | Stable |
| Product Sales (Agricultural Solutions) | Approximately 20% | Increasing |
| Other Income (Grants, etc.) | Approximately 10% | Varies |
Evogene Ltd.'s Business Economics
Evogene's business economics are rooted in its innovative approach to addressing agricultural and biological challenges. Here are some key aspects:
- R&D Investment: A significant portion of Evogene’s expenditure is allocated to research and development, reflecting its commitment to innovation.
- Strategic Collaborations: Partnerships enhance Evogene's capabilities and market reach, sharing costs and risks while accelerating technology adoption.
- Intellectual Property: Evogene relies heavily on its patent portfolio to protect its innovations and generate licensing revenue.
- Market Demand: The increasing global demand for sustainable agriculture and improved crop yields drives the need for Evogene's solutions.
Evogene Ltd.'s Financial Performance
Analyzing Evogene's financial performance involves considering several key indicators. Keep in mind that financial data can fluctuate, so it's good to check the most recent reports for the latest figures. For example, Breaking Down Evogene Ltd. (EVGN) Financial Health: Key Insights for Investors provides additional insights into Evogene's financial health.
- Revenue Growth: Monitor the year-over-year revenue growth to assess the company’s ability to expand its market presence and commercialize its technologies.
- Gross Margin: Evaluating the gross margin helps understand the profitability of Evogene's products and services.
- Operating Expenses: Analyzing operating expenses, particularly R&D costs, provides insights into the company’s investment in future growth.
- Net Income/Loss: Tracking net income or loss indicates overall financial health and the effectiveness of Evogene’s business model.
- Cash Flow: Reviewing cash flow from operations, investing, and financing activities is crucial for assessing liquidity and financial stability.
Evogene Ltd. (EVGN) Market Position & Future Outlook
Evogene is strategically positioned to leverage its innovative Ag-Biologicals to address the growing demand for sustainable agriculture, while navigating the inherent risks of biotechnology development and market adoption.
Competitive Landscape
The competitive landscape for Evogene is shaped by companies focusing on agricultural biotechnology and sustainable solutions. Market share data can fluctuate based on product approvals, partnerships, and technological advancements.
| Company | Market Share, % | Key Advantage |
|---|---|---|
| Evogene Ltd. | ~5% | Innovative Ag-Biologicals discovery and development platform |
| Bayer Crop Science | ~25% | Extensive portfolio of crop protection products and established market presence |
| Syngenta | ~20% | Strong focus on seeds and crop protection with global distribution network |
Opportunities & Challenges
Evogene faces both exciting opportunities and significant challenges as it strives to innovate in the Ag-Biologicals sector.
| Opportunities | Risks |
|---|---|
| Growing demand for sustainable agriculture and reduced chemical inputs. | Regulatory hurdles and lengthy approval processes for new biological products. |
| Potential for strategic partnerships with major agricultural companies to expand market reach. | Competition from established players with greater resources and market share. |
| Advancements in biotechnology and data analytics to accelerate product discovery and development. | Technological risks associated with developing novel biological solutions. |
Industry Position
Evogene's standing in the industry can be characterized by:
- Focus on innovative Ag-Biologicals, positioning it as a key player in sustainable agriculture.
- Emphasis on research and development, with a pipeline of novel products targeting unmet needs in crop protection and enhancement.
- Strategic collaborations to leverage expertise and resources for product development and commercialization.
To gain more insights into the company's financial performance, read this article: Breaking Down Evogene Ltd. (EVGN) Financial Health: Key Insights for Investors
Evogene Ltd. (EVGN) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.